Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven T Chen

Showing results (31-40 of 153) with videos related to

Pageof 16
Sort By:
JAAD International|June 16, 2022
Twitter as a tool for nail educationMelissa A Nickles, Lindsey J Gaghan, Steven T Chen, et al.
Journal of the American Academy of Dermatology|January 25, 2021
Limitations of morphology-based management for immune checkpoint inhibitor-related cutaneous adverse eventsTracey S Otto, Michael S Chang, Leah L Thompson, et al.
Journal of the American Academy of Dermatology|February 1, 2026
Risk of Malignancies and All-Cause Mortality in Patients with Pemphigus: A TriNetX Cohort StudyArjun Mahajan, Nathaniel S Treister, Kevin Sheng-Kai Ma, et al.
JAMA Dermatology|April 30, 2025
Secondary Cancer Risk Among Patients With Primary Cutaneous B-cell LymphomaVrusha K Shah, Sara Behbahani, Jeffrey Barnes, et al.
The American Journal of Medicine|March 25, 2019
Woman with Fatigue, Peripheral Neuropathy, Lower Extremity Edema, and Palpable Purpura: Type II CryoglobulinemiaConnie S Zhong, Sherry H Yu, Kristine M Cornejo, et al.
Journal of the American Academy of Dermatology|September 21, 2016
Type 2 diabetes mellitus and risk of cutaneous squamous cell carcinomaSteven T Chen, Tricia Li, Jiali Han, et al.
Journal of the American Academy of Dermatology|June 12, 2024
Effects of sodium-glucose cotransporter-2 inhibitors on inflammatory skin diseases in patients with type 2 diabetesKevin Sheng-Kai Ma, Serena Yun-Chen Tsai, Allison Holt, et al.
Diagnostics (Basel, Switzerland)|April 13, 2024
Cutaneous Intravascular Hematolymphoid Entities: A ReviewEmily Hatheway Marshall, Bethany Brumbaugh, Allison Holt, et al.
JAMA Dermatology|May 25, 2022
Association of Bullous Pemphigoid With Immune Checkpoint Inhibitor Therapy in Patients With Cancer: A Systematic ReviewMaria S Asdourian, Nishi Shah, Ted V Jacoby, et al.
BMJ Case Reports|January 2, 2023
Localised chronic fibrosing vasculitis versus erythema elevatum diutinumMika M Tabata, William M Lin, Jay Goldstein, et al.
Pageof 16

Showing results (31-40 of 153) with videos related to

Sort By:
Pageof 16
JAAD International|June 16, 2022
Twitter as a tool for nail educationMelissa A Nickles, Lindsey J Gaghan, Steven T Chen, et al.
Journal of the American Academy of Dermatology|January 25, 2021
Limitations of morphology-based management for immune checkpoint inhibitor-related cutaneous adverse eventsTracey S Otto, Michael S Chang, Leah L Thompson, et al.
Journal of the American Academy of Dermatology|February 1, 2026
Risk of Malignancies and All-Cause Mortality in Patients with Pemphigus: A TriNetX Cohort StudyArjun Mahajan, Nathaniel S Treister, Kevin Sheng-Kai Ma, et al.
JAMA Dermatology|April 30, 2025
Secondary Cancer Risk Among Patients With Primary Cutaneous B-cell LymphomaVrusha K Shah, Sara Behbahani, Jeffrey Barnes, et al.
The American Journal of Medicine|March 25, 2019
Woman with Fatigue, Peripheral Neuropathy, Lower Extremity Edema, and Palpable Purpura: Type II CryoglobulinemiaConnie S Zhong, Sherry H Yu, Kristine M Cornejo, et al.
Journal of the American Academy of Dermatology|September 21, 2016
Type 2 diabetes mellitus and risk of cutaneous squamous cell carcinomaSteven T Chen, Tricia Li, Jiali Han, et al.
Journal of the American Academy of Dermatology|June 12, 2024
Effects of sodium-glucose cotransporter-2 inhibitors on inflammatory skin diseases in patients with type 2 diabetesKevin Sheng-Kai Ma, Serena Yun-Chen Tsai, Allison Holt, et al.
Diagnostics (Basel, Switzerland)|April 13, 2024
Cutaneous Intravascular Hematolymphoid Entities: A ReviewEmily Hatheway Marshall, Bethany Brumbaugh, Allison Holt, et al.
JAMA Dermatology|May 25, 2022
Association of Bullous Pemphigoid With Immune Checkpoint Inhibitor Therapy in Patients With Cancer: A Systematic ReviewMaria S Asdourian, Nishi Shah, Ted V Jacoby, et al.
BMJ Case Reports|January 2, 2023
Localised chronic fibrosing vasculitis versus erythema elevatum diutinumMika M Tabata, William M Lin, Jay Goldstein, et al.
Pageof 16